{# ── Billing problem banner: payment failed (past_due) or retries exhausted (unpaid). Pro access is gated off by is_pro until the card is fixed, so prompt the user to update billing. ── #}
NASDAQ: CMMB Chemomab Therapeutics Ltd. 10-Q

Chemomab advances SSc and PSC trials but cash runway shortens to mid-2024

Filed May 11, 2023 · Period ending March 31, 2023 · Compared to 10-Q May 12, 2022 · ~1 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade CMMB commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Feedback
View original filing on SEC.gov

Generated by AI · May 24, 2026 2:59 AM